Home › Funds › PERCEPTIVE ADVISORS LLC › APGE

PERCEPTIVE ADVISORS LLC position in APGE

APOGEE THERAPEUTICS INC

PERCEPTIVE ADVISORS LLC reported holding 1,308,113 shares of APGE (APOGEE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$173.6M, representing 2.75% of its reported portfolio and ranking #11 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed APGE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.31M sh
Reported value held$173.63M
Portfolio Weight2.75%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PERCEPTIVE ADVISORS LLC's APGE position evolved

PERCEPTIVE ADVISORS LLC first disclosed a stake in APGE in Q3 2023 at 1,827,901 shares (US$38.9M). The position peaked in Q4 2025 at 2,330,651 shares, worth US$175.9M. Across 12 filings, PERCEPTIVE ADVISORS LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,308,113 shares valued at US$173.6M — a reduction of -232,271 shares quarter over quarter.. Notable position changes include a 48% trim in Q4 2024, a 72% increase in Q4 2025, a 34% trim in Q1 2026.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.83M $38.93M New
Q4 2023 1.83M $51.07M Hold
Q1 2024 2.06M $136.91M Add
Q2 2024 2.11M $82.86M Add
Q3 2024 2.02M $118.36M Reduce
Q4 2024 1.05M $47.44M Reduce
Q1 2025 1.12M $41.95M Add
Q2 2025 1.18M $51.34M Add
Q3 2025 1.35M $53.71M Add
Q4 2025 2.33M $175.92M Add
Q1 2026 1.54M $129.65M Reduce
Q2 2026 1.31M $173.63M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APGE and 13F data

APGE (APOGEE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 59 other funds we track also report a position in APGE — the largest reported positions include Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$231.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APGE

All APGE fund holders →

FAQ

How long has PERCEPTIVE ADVISORS LLC held APGE?

PERCEPTIVE ADVISORS LLC has disclosed APGE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is PERCEPTIVE ADVISORS LLC's current position in APGE?

As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 1.31M shares of APGE (APOGEE THERAPEUTICS INC), valued at $173.63M, representing 2.75% of its reported portfolio and ranking #11.

Has PERCEPTIVE ADVISORS LLC been buying or selling APGE?

In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC reduced its position in APGE. The position peaked in Q4 2025 at 2.33M shares.

Which other funds hold APGE?

Other major institutional holders of APGE include Venrock Adviser, LLC, HBK INVESTMENTS L P, DRIEHAUS CAPITAL MANAGEMENT LLC, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.